Rationale and design of the Prevent Anal Cancer Self-Swab Study: a protocol for a randomised clinical trial of home-based self-collection of cells for anal cancer screening.
Rationale and design of the Prevent Anal Cancer Self-Swab Study: a protocol for a randomised clinical trial of home-based self-collection of cells for anal cancer screening.
复制标题
DOI:
10.1136/bmjopen-2021-051118
复制
发表时间:
2021-06-29
期刊:
影响因子:
2.9
通讯作者:
Chiao EY
中科院分区:
文献类型:
--
作者:
Nyitray AG;Schick V;Swartz MD;Giuliano AR;Fernandez ME;Deshmukh AA;Ridolfi TJ;Ajala C;Brzezinski B;Sandoval M;Nedjai B;Smith JS;Chiao EY
Squamous cell carcinoma of the anus is a common cancer among sexual minority men, especially HIV-positive sexual minority men; however, there is no evidenced-based national screening protocol for detection of anal precancers. Our objective is to determine compliance with annual anal canal self-sampling or clinician-sampling for human papillomavirus (HPV) DNA. This is a prospective, randomised, two-arm clinical study to evaluate compliance with annual home-based versus clinic-based HPV DNA screening of anal canal exfoliated cells. The setting is primary care community-based clinics. Recruitment is ongoing for 400 HIV-positive and HIV-negative sexual minority men and transgender persons, aged >25 years, English or Spanish speaking, no current use of anticoagulants other than nonsteroidal anti-inflammatory drugs and no prior diagnosis of anal cancer. Participants are randomised to either receive a swab in the mail for home-based collection of an anal canal specimen at 0 and 12 months (arm 1) or attend a clinic for clinician collection of an anal canal specimen at 0 and 12 months (arm 2). Persons will receive clinic-based Digital Anal Rectal Examinations and high-resolution anoscopy-directed biopsy to assess precancerous lesions, stratified by study arm. Anal exfoliated cells collected in the study are assessed for high-risk HPV persistence and host/viral methylation. The primary analysis will use the intention-to-treat principle to compare the proportion of those who comply with 0-month and 12-month sampling in the home-based and clinic-based arms. The a priori hypothesis is that a majority of persons will comply with annual screening with increased compliance among persons in the home-based arm versus clinic-based arm. The study has been approved by the Medical College of Wisconsin Human Protections Committee. Results will be disseminated to communities where recruitment occurred and through peer-reviewed literature and conferences. NCT03489707.
登录
查看更多内容
影响因子:
3.7
作者:
Darragh, Teresa M.;Colgan, Terence J.;Wilbur, David C.
通讯作者:
Wilbur, David C.
DOI:
10.1097/00126334-200408010-00004
发表时间:
2004-08-01
影响因子:
3.6
作者:
Cranston, RD;Darragh, TM;Palefsky, JM
通讯作者:
Palefsky, JM
影响因子:
3.7
作者:
Hillman, Richard John;Berry-Lawhorn, J. Michael;Jay, Naomi
通讯作者:
Jay, Naomi
影响因子:
3.1
作者:
Carter, Jarvis W., Jr.;Hart-Cooper, Geoffrey D.;Hoover, Karen W.
通讯作者:
Hoover, Karen W.
影响因子:
6.4
作者:
Clifford GM;Georges D;Shiels MS;Engels EA;Albuquerque A;Poynten IM;de Pokomandy A;Easson AM;Stier EA
通讯作者:
Stier EA